糖尿病视网膜病变眼中的4型黄斑新生血管
该回顾性分析纳入9只无年龄相关性黄斑变性(AMD)特征的糖尿病视网膜病变(DR)眼,经OCT和OCTA确诊为4型黄斑新生血管(T4MNV)。患者平均年龄64岁,糖尿病平均病程20年,患眼平均视力20/500,7/9眼为增殖性DR。结论提示T4MNV可发生于长期DR且无AMD征象的眼,早期识别T4MNV影像特征对告知视力预后很重要。
要点
- 长期DR无AMD征象的眼可发生T4MNV,患眼视力预后差。
- 9只患眼均见视网膜下高反射物质,对应OCT/OCTA上的2型和1型MNV。
- 7/9眼为增殖性DR,其余为重度非增殖性DR。
核心结论
- T4MNV可发生于长期DR且无AMD征象的眼。
- 早期识别T2MNV并及时抗VEGF干预可能减缓向T4MNV进展,但需前瞻性研究验证。
- 早期识别T4MNV影像特征有助于向患者说明视力预后不良。
研究设计与样本
- 回顾性分析纳入9只糖尿病视网膜病变眼,均无年龄相关性黄斑变性特征,经OCT和OCTA显示T4MNV。
主要发现
- 患者平均年龄64岁,糖尿病平均病程20年。
- 所有患者为单侧T4MNV,患眼平均视力20/500。
- 7/9眼(77.8%)为增殖性DR,其余为重度非增殖性DR。
- 7/9眼(77.8%)检测到中心后玻璃体纤维化,其中4/9眼(44.4%)在OCTA上显示血流。
- 9只患眼均见视网膜下高反射物质,对应OCT和OCTA上的2型(及1型)MNV;9只患眼及对侧眼均未检测到玻璃膜疣。
关键数值与推荐
- T4MNV诊断依据OCT和OCTA影像特征。
- 患眼平均视力20/500,7/9眼(77.8%)为增殖性DR。
- 中心后玻璃体纤维化7/9眼(77.8%),OCTA显示血流4/9眼(44.4%)。
临床怎么用
- 对长期DR患者应关注OCT/OCTA上T4MNV的影像特征。
- 发现T2MNV时可考虑及时抗VEGF干预以可能减缓向T4MNV进展(需前瞻性验证)。
- 识别T4MNV特征有助于向患者说明视力预后不良。
局限性
- 回顾性分析,样本量仅9只眼。
- 早期识别T2MNV并抗VEGF干预可减缓T4MNV进展的推测需前瞻性分析验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report recently described type 4 macular neovascularization (T4MNV) in eyes with diabetic retinopathy (DR). METHODS: A retrospective analysis including nine eyes with DR (and without any features of age related macular degeneration or AMD) that displayed T4MNV with optical coherence tomography (OCT) and OCT angiography (OCTA). RESULTS: The mean age of the patients was 64 years, and the mean duration of diabetes mellitus was 20 years. All patients displayed unilateral T4MNV with an average visual acuity of 20/500 in the affected eye. Seven of the nine patients (77.8%) were diagnosed with proliferative DR, and the remaining exhibited severe non-proliferative DR. Central posterior hyaloid fibrosis was detected in 7/9 eyes (77.8%) and showed flow on OCTA in 4/9 eyes (44.4%). All 9 eyes showed subretinal hyperreflective material (SHRM) on OCT corresponding to Type 2 (and Type 1) MNV on OCT and OCTA. Drusen were not detected in any of the 9 affected or fellow eyes. CONCLUSION: T4MNV can occur in eyes with long-standing DR without signs of AMD. It is possible that early identification of T2MNV and timely anti-VEGF intervention may potentially mitigate progression to T4MNV, but this requires validation with prospective analysis. Early recognition of T4MNV imaging features is important in counseling patients about the poor visual prognosis.
引用
- Baddar D, Fouad Y, Salem NO, et al. Type 4 macular neovascularization in eyes with diabetic retinopathy. Retina. 2026. PMID: 42530462. doi:10.1097/IAE.0000000000004948
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。